{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:06:02Z","timestamp":1781276762133,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.numecd.2023.03.003","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T03:26:27Z","timestamp":1678677987000},"page":"1349-1357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Sex differences in cardiovascular and all-cause mortality in nonalcoholic fatty liver disease in the US population"],"prefix":"10.1016","volume":"33","author":[{"given":"Ruirui","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2023.03.003_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2023.03.003_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease \u2013 a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.03.003_bib3","doi-asserted-by":"crossref","first-page":"ITC65","DOI":"10.7326\/AITC201811060","article-title":"Nonalcoholic fatty liver disease","volume":"169","author":"Wang","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2023.03.003_bib4","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American heart association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2023.03.003_bib5","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/hep.29546","article-title":"Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: a 20 year-community study","volume":"67","author":"Allen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.03.003_bib6","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2023.03.003_bib7","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.03.003_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s10620-011-1819-3","article-title":"The relationship between arterial stiffness and nonalcoholic fatty liver disease","volume":"57","author":"Lee","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.numecd.2023.03.003_bib9","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3748\/wjg.v11.i12.1848","article-title":"Hepatic steatosis is associated with an increased risk of carotid atherosclerosis","volume":"11","author":"Volzke","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.numecd.2023.03.003_bib10","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/HJH.0b013e32833a7de6","article-title":"Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study","volume":"28","author":"Salvi","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2023.03.003_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.20781","article-title":"Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease","volume":"42","author":"Villanova","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.03.003_bib12","doi-asserted-by":"crossref","first-page":"14185","DOI":"10.3748\/wjg.v20.i39.14185","article-title":"Nonalcoholic fatty liver disease and aging: epidemiology to management","volume":"20","author":"Bertolotti","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.numecd.2023.03.003_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142937","article-title":"Non-Alcoholic fatty liver disease as a predictor of atrial fibrillation in middle-aged population (OPERA study)","volume":"10","author":"K\u00e4r\u00e4j\u00e4m\u00e4ki","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2023.03.003_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001820","article-title":"Nonalcoholic fatty liver disease is associated with QT prolongation in the general population","volume":"4","author":"Hung","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2023.03.003_bib15","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2337\/dc16-0091","article-title":"Nonalcoholic fatty liver disease is associated with ventricular arrhythmias in patients with type 2 diabetes referred for clinically indicated 24-hour holter monitoring","volume":"39","author":"Mantovani","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2023.03.003_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41575-018-0010-0","article-title":"Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease","volume":"15","author":"Anstee","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2023.03.003_bib17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2008.06.018","article-title":"Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease","volume":"49","author":"Ong","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.03.003_bib18","first-page":"258","article-title":"Increased cardiovascular events and mortality in females with NAFLD: a meta-analysis","volume":"10","author":"Khalid","year":"2020","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2023.03.003_bib19","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jhep.2012.07.028","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study","volume":"57","author":"Koehler","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.03.003_bib20","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/j.1572-0241.2008.02034.x","article-title":"Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study","volume":"103","author":"Dunn","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.numecd.2023.03.003_bib21","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.numecd.2023.03.003_bib22","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1478-3231.2004.0969.x","article-title":"Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients","volume":"24","author":"Kagansky","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.numecd.2023.03.003_bib23","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/acel.12128","article-title":"Liver diseases and aging: friends or foes?","volume":"12","author":"Sheedfar","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.numecd.2023.03.003_bib24","unstructured":"Centers for Disease Control and Prevention. National center for health Statistics. https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/."},{"key":"10.1016\/j.numecd.2023.03.003_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States national health and nutrition examination survey","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.numecd.2023.03.003_bib26","article-title":"Higher serum 25-hydroxyvitamin D is associated with lower all-cause and cardiovascular mortality among US adults with nonalcoholic fatty liver disease","volume":"14","author":"Chen","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.numecd.2023.03.003_bib27","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/hep.32207","article-title":"High-quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population","volume":"75","author":"Vilar-Gomez","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.03.003_bib28","doi-asserted-by":"crossref","first-page":"11124","DOI":"10.1038\/s41598-019-47687-3","article-title":"Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis","volume":"9","author":"Liu","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.numecd.2023.03.003_bib29","first-page":"12","article-title":"Gender gaps--Life expectancy and proportion of life in poor health","volume":"25","author":"Luy","year":"2014","journal-title":"Health Rep"},{"key":"10.1016\/j.numecd.2023.03.003_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13293-022-00475-7","article-title":"Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study","volume":"13","author":"Fresneda","year":"2022","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.numecd.2023.03.003_bib31","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2023.03.003_bib32","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/eurjpc\/zwab212","article-title":"Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"29","author":"Alon","year":"2021","journal-title":"Eur J Preve Cardiol"},{"key":"10.1016\/j.numecd.2023.03.003_bib33","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2023.03.003_bib34","article-title":"Association of NAFLD with cardiovascular disease and all-cause mortality: a large-scale prospective cohort study based on UK Biobank","volume":"13","author":"Ma","year":"2022","journal-title":"Therap Adv Chron Dis"},{"key":"10.1016\/j.numecd.2023.03.003_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2023.03.003_bib36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cca.2017.11.026","article-title":"Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease","volume":"476","author":"Ndrepepa","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.numecd.2023.03.003_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.20517\/mtod.2022.20","article-title":"Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk","volume":"2","author":"Lonardo","year":"2022","journal-title":"Metabol Target Organ Damage"},{"key":"10.1016\/j.numecd.2023.03.003_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11010098","article-title":"Liver fibrosis biomarkers accurately exclude advanced fibrosis and are associated with higher cardiovascular risk scores in patients with NAFLD or viral chronic liver disease","volume":"11","author":"Ballestri","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.numecd.2023.03.003_bib39","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.03.003_bib40","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2023.03.003_bib41","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/liv.14943","article-title":"Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)","volume":"41","author":"Burra","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.numecd.2023.03.003_bib42","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.32519","article-title":"Risk of cardiovascular disease and loss in life expectancy in NAFLD","volume":"76","author":"Shang","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2023.03.003_bib43","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.14309\/ajg.0000000000000401","article-title":"Women with nonalcoholic fatty liver disease lose protection against cardiovascular disease: a longitudinal cohort study","volume":"114","author":"Allen","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.numecd.2023.03.003_bib44","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","article-title":"NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk","volume":"34","author":"Ballestri","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.numecd.2023.03.003_bib45","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1017\/S0029665121003815","article-title":"Non-alcoholic fatty liver disease: a multi-system disease influenced by ageing and sex, and affected by adipose tissue and intestinal function","volume":"81","author":"Bilson","year":"2022","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.numecd.2023.03.003_bib46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12876-019-0972-6","article-title":"Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States","volume":"19","author":"Golabi","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.numecd.2023.03.003_bib47","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2147\/CIA.S295524","article-title":"NAFLD in the elderly","volume":"16","author":"Alqahtani","year":"2021","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.numecd.2023.03.003_bib48","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","article-title":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"59","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2023.03.003_bib49","first-page":"9026","article-title":"Role of liver biopsy in nonalcoholic fatty liver disease","volume":"20","author":"Nalbantoglu","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.numecd.2023.03.003_bib50","first-page":"7","article-title":"Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies","volume":"1","author":"Ballestri","year":"2021","journal-title":"Metabol Target Organ Damage"},{"key":"10.1016\/j.numecd.2023.03.003_bib51","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2021.04.044","article-title":"Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis","volume":"75","author":"Selvaraj","year":"2021","journal-title":"J Hepatol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475323000881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475323000881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:24:12Z","timestamp":1760545452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475323000881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0939475323000881"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2023.03.003","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex differences in cardiovascular and all-cause mortality in nonalcoholic fatty liver disease in the US population","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2023.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}